OxySure Systems, Inc. (OTCQB:OXYS) is a medical device company with a potential breakthrough product for the delivery of medical grade oxygen for the treatment of cardiac and respiratory distress situations. The company has developed a unique platform technology, whereby medically pure oxygen is created instantly from two inert dry powders, allowing oxygen to be delivered on demand to patients when needed.
The Model 615 unit has been cleared by the U.S. Food and Drug Administration (FDA) for over-the-counter (OTC) sale without the need for a prescription (510k/Class-II). The product is also approved in South Africa, Turkey, Brazil, and Israel.
OxySure Model 615
With the Model 615 unit, oxygen is generated on demand from two inert...
Only subscribers can access this article, which is part of the PRO research library covering 3,809 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: